BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 29184052)

  • 1. Notch transactivates Rheb to maintain the multipotency of TSC-null cells.
    Cho JH; Patel B; Bonala S; Manne S; Zhou Y; Vadrevu SK; Patel J; Peronaci M; Ghouse S; Henske EP; Roegiers F; Giannikou K; Kwiatkowski DJ; Mansouri H; Markiewski MM; White B; Karbowniczek M
    Nat Commun; 2017 Nov; 8(1):1848. PubMed ID: 29184052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The evolutionarily conserved TSC/Rheb pathway activates Notch in tuberous sclerosis complex and Drosophila external sensory organ development.
    Karbowniczek M; Zitserman D; Khabibullin D; Hartman T; Yu J; Morrison T; Nicolas E; Squillace R; Roegiers F; Henske EP
    J Clin Invest; 2010 Jan; 120(1):93-102. PubMed ID: 20038815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Codon 72
    Cho JH; Patel B; Bonala S; Mansouri H; Manne S; Vadrevu SK; Ghouse S; Kung CP; Murphy ME; Astrinidis A; Henske EP; Kwiatkowski DJ; Markiewski MM; Karbowniczek M
    Mol Cancer Res; 2019 Aug; 17(8):1639-1651. PubMed ID: 31088907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tuberin Regulates Prostaglandin Receptor-Mediated Viability, via Rheb, in mTORC1-Hyperactive Cells.
    Li C; Liu X; Liu Y; Zhang E; Medepalli K; Masuda K; Li N; Wikenheiser-Brokamp KA; Osterburg A; Borchers MT; Kopras EJ; Plas DR; Sun J; Franz DN; Capal JK; Mays M; Sun Y; Kwiatkowski DJ; Alayev A; Holz MK; Krueger DA; Siroky BJ; Yu JJ
    Mol Cancer Res; 2017 Oct; 15(10):1318-1330. PubMed ID: 28710231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of gene expression array in TSC2-deficient AML cells reveals IRF7 as a pivotal factor in the Rheb/mTOR pathway.
    Makovski V; Jacob-Hirsch J; Gefen-Dor C; Shai B; Ehrlich M; Rechavi G; Kloog Y
    Cell Death Dis; 2014 Dec; 5(12):e1557. PubMed ID: 25476905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Farnesylthiosalicylic acid (salirasib) inhibits Rheb in TSC2-null ELT3 cells: a potential treatment for lymphangioleiomyomatosis.
    Makovski V; Haklai R; Kloog Y
    Int J Cancer; 2012 Mar; 130(6):1420-9. PubMed ID: 21500191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The TSC-2 product tuberin is expressed in lymphangioleiomyomatosis and angiomyolipoma.
    Johnson SR; Clelland CA; Ronan J; Tattersfield AE; Knox AJ
    Histopathology; 2002 May; 40(5):458-63. PubMed ID: 12010366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the CXCR4/CXCL12 axis in lymphangioleiomyomatosis and angiomyolipoma.
    Clements D; Markwick LJ; Puri N; Johnson SR
    J Immunol; 2010 Aug; 185(3):1812-21. PubMed ID: 20585037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapamycin-insensitive up-regulation of adipocyte phospholipase A2 in tuberous sclerosis and lymphangioleiomyomatosis.
    Li C; Zhang E; Sun Y; Lee PS; Zhan Y; Guo Y; Osorio JC; Rosas IO; Xu KF; Kwiatkowski DJ; Yu JJ
    PLoS One; 2014; 9(10):e104809. PubMed ID: 25347447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosomes mediate the acquisition of the disease phenotypes by cells with normal genome in tuberous sclerosis complex.
    Patel B; Patel J; Cho JH; Manne S; Bonala S; Henske E; Roegiers F; Markiewski M; Karbowniczek M
    Oncogene; 2016 Jun; 35(23):3027-36. PubMed ID: 26434588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuberous Sclerosis Complex: State-of-the-Art Review with a Focus on Pulmonary Involvement.
    von Ranke FM; Zanetti G; e Silva JL; Araujo Neto CA; Godoy MC; Souza CA; Mançano AD; Souza AS; Escuissato DL; Hochhegger B; Marchiori E
    Lung; 2015 Oct; 193(5):619-27. PubMed ID: 26104489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen enhances whereas tamoxifen retards development of Tsc mouse liver hemangioma: a tumor related to renal angiomyolipoma and pulmonary lymphangioleiomyomatosis.
    El-Hashemite N; Walker V; Kwiatkowski DJ
    Cancer Res; 2005 Mar; 65(6):2474-81. PubMed ID: 15781664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Animal models of lymphangioleiomyomatosis (LAM) and tuberous sclerosis complex (TSC).
    Kwiatkowski DJ
    Lymphat Res Biol; 2010 Mar; 8(1):51-7. PubMed ID: 20235887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-gamma-Jak-Stat signaling in pulmonary lymphangioleiomyomatosis and renal angiomyolipoma: a potential therapeutic target.
    El-Hashemite N; Kwiatkowski DJ
    Am J Respir Cell Mol Biol; 2005 Sep; 33(3):227-30. PubMed ID: 15994429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of tuberous sclerosis complex 1 (Tsc1) expression results in increased Rheb/S6K pathway signaling important for astrocyte cell size regulation.
    Uhlmann EJ; Li W; Scheidenhelm DK; Gau CL; Tamanoi F; Gutmann DH
    Glia; 2004 Aug; 47(2):180-8. PubMed ID: 15185396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the oestrogen response in an angiomyolipoma derived xenograft model.
    Clements D; Asprey SL; McCulloch TA; Morris TA; Watson SA; Johnson SR
    Endocr Relat Cancer; 2009 Mar; 16(1):59-72. PubMed ID: 18988705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ubiquitination of Rheb governs growth factor-induced mTORC1 activation.
    Deng L; Chen L; Zhao L; Xu Y; Peng X; Wang X; Ding L; Jin J; Teng H; Wang Y; Pan W; Yu F; Liao L; Li L; Ge X; Wang P
    Cell Res; 2019 Feb; 29(2):136-150. PubMed ID: 30514904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogenic effects of urotensin-II in cells lacking tuberous sclerosis complex-2.
    Goldberg AA; Joung KB; Mansuri A; Kang Y; Echavarria R; Nikolajev L; Sun Y; Yu JJ; Laporte SA; Schwertani A; Kristof AS
    Oncotarget; 2016 Sep; 7(38):61152-61165. PubMed ID: 27458154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphangioleiomyomatosis and TSC2-/- cells.
    Darling TN; Pacheco-Rodriguez G; Gorio A; Lesma E; Walker C; Moss J
    Lymphat Res Biol; 2010 Mar; 8(1):59-69. PubMed ID: 20235888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rheb activation disrupts spine synapse formation through accumulation of syntenin in tuberous sclerosis complex.
    Sugiura H; Yasuda S; Katsurabayashi S; Kawano H; Endo K; Takasaki K; Iwasaki K; Ichikawa M; Kobayashi T; Hino O; Yamagata K
    Nat Commun; 2015 Apr; 6():6842. PubMed ID: 25880340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.